There is a new MS drug that has just received FDA approval. I've been trying to post a link to an article about it. I'll give it one more try.
That didn't work. I don't know why I sometimes get a message saying that my post request can't be fulfilled, but I'll try posting without the link and see what happens.
The drug's brand name is Kesimpta (ofatumumab) and is described as follows in the article I couldn't link to:
Quote:
|
Novartis today announced that the US Food and Drug Administration (FDA) has approved KesimptaŽ (ofatumumab, formerly OMB157) as an injection for subcutaneous use for the treatment of relapsing forms of multiple sclerosis (RMS), to include clinically isolated syndrome, relapsing-remitting disease, and active secondary progressive disease, in adults. Kesimpta is a targeted, precisely dosed and delivered B-cell therapy that has shown superior efficacy with a similar safety profile compared with teriflunomide and is a first-choice treatment option for RMS patients1. Kesimpta is the first B-cell therapy that can be self-administered once monthly at home via the SensoreadyŽ autoinjector pen.
|
--from a Novartis press release dated 8/20/20.